What are Syngenta’s corporate headquarters address and telephone number?
The global headquarter of Syngenta is located in Basel, Switzerland:
Syngenta International AG
Phone: +41 61 323 11 11
What is Syngenta’s vision & main areas of activity?
Syngenta is one of the world's leading companies with more than 27,000 employees in some 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Click here to learn more about us.
How often is your Web site updated?
The Investor and Media Centers are updated frequently. Our Stock Information is updated several times per hour. Most of the general information on the site will not be updated as often because it is unlikely to become dated.
What is Syngenta’s Stock Ticker and what exchange is Syngenta traded on?
Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT).
|Exchange: SIX Swiss ( Zurich )
Syngenta AG (ADR)
|Exchange: NYSE ( New York )
How do I get printed copies of Syngenta’s financial information?
You can order printed copies of the complete audited financial statements by contacting us here:
Or write us to the following address:
Syngenta International AG
When is the company's year end?
Who is your independent auditor?
Ernst & Young was appointed as Group auditor at the Annual General Meeting in April 2002. The appointment of the auditor is for one year, renewable annually.
What currency are your financial statements prepared?
Our consolidated financial results are prepared in US dollars in accordance with International Financial Reporting Standards (“IFRS”).
When does the next Annual General Meeting (“AGM”) take place?
The next AGM will take place on April 23, 2013.
Click here for more information on our Calendar of Events.
Who are Syngenta's key management members?
||Date of birth
||Chief Executive Officer
||Chief Operating Officer
||Head of Business Development
Ad Interim Head of Research & Development
||Head of Human Resources
||Head of Legal & Taxes
and Company Secretary
||Head of Global Operations
||Chief Operating Officer
||Chief Financial Officer
Click here to learn more about our Executive Committee.
How many employees does Syngenta have?
To meet the needs of individual markets, we have a global total of more than 27,000 people in over 90 countries.
What are your key financial targets?
As part of the implementation of our new strategy our financial objectives are based upon three key measures: EBITDA margin, cash flow return on investment and cash return to shareholders.
We are targeting an EBITDA margin of 22-24% by 2015 thereby reflecting our continued commitment to profitable growth.
We have introduced cash flow return on investment as a new measure targeting to maintain a level in excess of 12%, which represents a commitment to continuing strong cash generation at attractive levels of return on investment.
We will continue to return significant cash to shareholders. This will be through a cash return policy which prioritizes dividend growth. Share buybacks will be used tactically when the balance sheet and acquisition outlook allows.
What levels of cash do you return to your shareholders?
We expect strong cash generation to continue as an ongoing feature of our business. This will provide us with the flexibility to target a continuous increase in the dividend as well as continue to seek out acquisitions.
The total cash return for the period 2005-2012 was over $6.3 billion.
In 2011, a dividend of CHF 7.00 per share was paid on 28 April 2011 representing a cash return of $705 million. In addition we completed a further $198 million share repurchase in 2011.
In 2012 a dividend of CHF 8.00 per share was approved at the AGM on 24 April, 2012 and paid in cash on 02 May 2012 representing a cash return of $791 million.
What do you pay to your shareholders in the form of dividends?
For 2013 the proposed dividend is CHF 9.50 subject to approval at the AGM on 23 April 2013.
The 2012 dividend was CHF 8.00 and was paid in cash on 02 May 2012 based on an ex-dividend date of 26 April 2012.
The 2011 dividend was CHF 7.00 and was paid in cash on 28 April 2011 based on an ex-dividend date of 21 April 2011. It was paid from our share premium reserves, rendering it free from withholding tax.
The 2010 dividend was CHF 6.00 and was paid in cash on 27 April 2010 based on an ex-dividend date of 22 April 2010.
The 2009 dividend was CHF 6.00 and was paid in cash on 24 April 2009 based on an ex-dividend date of 24 April 2009.
What is your Weighted Average Cost of Capital (“WACC”)?
Our WACC is estimated at approximately 6.1%.
What are your debt ratings?
Both rating agencies reviewed Syngenta in the second half of 2012 and reconfirmed their ratings based on our leading market positions, high level of geographical diversification, strong business profile supported the track-record of delivering innovative solutions, and our balanced approach to managing growth and shareholder returns.
Where can I obtain more information?
You can reach our Investor Relations team via email or on the following numbers:
||+41 (0)61 323 5059|
||+1 (202) 737 6521|
||+41 (0)61 323 6793|
||+1 (202) 737 6520|
This site contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.